logo

For the Inventor, By the Inventor

Maidenhead, United Kingdom

Albert Opalko

USPTO Granted Patents = 15

Average Co-Inventor Count = 2.4

ph-index = 3

Forward Citations = 26(Granted Patents)


Company Filing History:

goldMedal14 out of 299 
 
John Wyeth Brother, Limited
 patents
silverMedal1 out of 1,567 
 
American Home Products Corporation
 patents

Years Active: 1982-1999

Loading Chart...
15 patents (USPTO):Explore Patents
1. 5965696 - Potassium channel modulators (1999-10-12),
2. 5821251 - Nitrogen heterocycles (1998-10-13),
3. 5708026 - Cyclohexane derivatives (1998-01-13),
4. 5681839 - Nitrogen heterocycles (1997-10-28),
5. 5604238 - Z-benzylidene-tetrahydroquinolines and analogues thereof (1997-02-18),
6. 5597834 - Z-benzylidene-tetrahydroquinolines and analogues thereof (1997-01-28),
7. 5112832 - Certain cyclopenta[b]pyridines and 5,6,7,8-tetrahydroquinolines having (1992-05-12),
8. 5068337 - 1,4-dihydropyridines and their ability to inhibit blood platelet (1991-11-26),
9. 5064842 - 1,4-dihydropyridines (1991-11-12),
10. 5001131 - Pyridine derivatives (1991-03-19),
11. 4983617 - Stable crystal form of (1991-01-08),
12. 4975431 - Certain anti-inflammatory cyclohepta[b]pyridines and analogs thereof (1990-12-04),
13. 4900750 - 1.4-Dihydropyridines (1990-02-13),
14. 4694012 - Method of treating of preventing diseases using 1,4-dihydropyridines (1987-09-15),
15. 4358452 - N-[1,2,3,4,6,7,12,12 (1982-11-09),

Title: Albert Opalko - Innovator and Inventor in Biopharmaceuticals

Introduction

Albert Opalko is a distinguished inventor based in Maidenhead, Great Britain. With a significant contribution to the field of biopharmaceuticals, he holds an impressive portfolio of 15 patents. His work has had a profound impact on the development of various medical therapies.

Latest Patents

Among his notable innovations, Albert's latest patents include advancements in potassium channel modulators. This invention focuses on peptides that exhibit intracellular potassium channel modulating activity, specifically incorporating the amino acid sequence identified as SEQ ID No: 2. Additionally, he has made strides in the realm of nitrogen heterocycles, reflecting his dedication to exploring innovative pharmaceutical solutions.

Career Highlights

Throughout his career, Albert Opalko has worked for prominent companies in the biopharmaceutical sector, notably John Wyeth & Brother Limited and American Home Products Corporation. His experience in these organizations has allowed him to harness his skills in research and development, ultimately leading to his impressive patent portfolio.

Collaborations

Albert's journey has also involved collaborations with esteemed colleagues, including Roger Crossley and John Leheup Archibald. These partnerships have played a crucial role in driving forward the innovative projects he has been involved in and have contributed to his successful career as an inventor.

Conclusion

In conclusion, Albert Opalko stands out as a key figure in the field of biopharmaceutical innovation. His 15 patents showcase his commitment to advancing medical science through creative solutions and collaborative efforts. His ongoing work continues to inspire future innovators in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…